Ann Robinson’s research reviews—3 December 2021
Living long enough to benefit from treatmentBisphosphonates are the main drugs on offer for fracture prevention in osteoporosis. But they can be a hard sell to patients who are concerned about the…
Read Original Article: Ann Robinson’s research reviews—3 December 2021 »
